Medicine & Life Sciences

1. Alzheimer Disease 100%
2. Amyloid 53%
3. Cognitive Dysfunction 45%
4. Atrophy 42%
5. Neuroimaging 35%
6. Brain 32%
7. Biomarkers 29%
8. Magnetic Resonance Imaging 25%
9. White Matter 24%
10. 2-(4'-(methylamino)phenyl)-6-hydroxybenzothiazole 23%
11. Dementia 20%
12. Positron-Emission Tomography 18%
13. 7-(6-fluoropyridin-3-yl)-5H-pyrido(4,3-b)indole 17%
14. Temporal Lobe 16%
15. Pathology 15%
16. Cognition 12%
17. Progressive Supranuclear Palsy 12%
18. Cerebrospinal Fluid 11%
19. Gray Matter 10%
20. Elderly 10%
21. Aphasia 9%
22. Frontotemporal Dementia 9%
23. Hippocampus 9%
24. Apraxias 9%
25. Primary Progressive Aphasia 8%
26. Frontotemporal Lobar Degeneration 8%
27. Memory 7%
28. Apolipoprotein E4 7%
29. Diffusion Tensor Imaging 7%
30. Parietal Lobe 6%
31. Disease Progression 6%
32. Clinical Trials 6%
33. Anisotropy 6%
34. Population 5%
35. Amyloid Plaques 5%
36. Atherosclerosis 5%
37. Mental Status and Dementia Tests 5%
38. Apolipoproteins E 5%